000			02068 a2200589 4500
005			20250516083036.0
264		0	_c20120716
008			201207s 0 0 eng d
022			_a1528-0020
024	7		_a10.1182/blood-2011-11-395749 _2doi
040			_aNLM _beng _cNLM
100	1		_aKumar, Shaji
245	0	0	_aRandomized, multicenter, phase 2 study (EVOLUTION) of combinations of bortezomib, dexamethasone, cyclophosphamide, and lenalidomide in previously untreated multiple myeloma. _h[electronic resource]
260			_bBlood _cMay 2012
300			_a4375-82 p. _bdigital
500			_aPublication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
650	0	4	_aAdult
650	0	4	_aAged
650	0	4	_aAged, 80 and over
650	0	4	_aAlgorithms
650	0	4	_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects
650	0	4	_aBoronic Acids _xadministration & dosage
650	0	4	_aBortezomib
650	0	4	_aCyclophosphamide _xadministration & dosage
650	0	4	_aDexamethasone _xadministration & dosage
650	0	4	_aFemale
650	0	4	_aHumans
650	0	4	_aLenalidomide
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aMultiple Myeloma _xdrug therapy
650	0	4	_aNeoadjuvant Therapy
650	0	4	_aPyrazines _xadministration & dosage
650	0	4	_aThalidomide _xadministration & dosage
650	0	4	_aTreatment Outcome
700	1		_aFlinn, Ian
700	1		_aRichardson, Paul G
700	1		_aHari, Parameswaran
700	1		_aCallander, Natalie
700	1		_aNoga, Stephen J
700	1		_aStewart, A Keith
700	1		_aTurturro, Francesco
700	1		_aRifkin, Robert
700	1		_aWolf, Jeffrey
700	1		_aEstevam, Jose
700	1		_aMulligan, George
700	1		_aShi, Hongliang
700	1		_aWebb, Iain J
700	1		_aRajkumar, S Vincent
773	0		_tBlood _gvol. 119 _gno. 19 _gp. 4375-82
856	4	0	_uhttps://doi.org/10.1182/blood-2011-11-395749 _zAvailable from publisher's website
999			_c21627501 _d21627501